Xarelto® - First in Oral, Direct Factor Xa Inhibition « knee-surgery

(Klikk: 318;lagt til nettsted: Jun 22, 2015, knee-surgery)

(Siste oppdatering: 22. November 2011) - Xarelto® (rivaroxaban) is a direct Factor Xa inhibitor taken as one tablet, once-daily. On September 30, 2008. the European Commission granted marketing approval for 'Xarelto' for the prevention of venous blood

xarelto rivaroxaban tablet blood clots hip surgery knee surgery